FDA 510(k)

NEUROShield

K-Number: K220034 · 2023-09-14

Decision Date2023-09-14

Product CodeLLZ

Advisory CommitteeRA

DecisionSubstantially Equivalent

Device Summary

NEUROShield is the device name listed in this FDA 510(k) record. The listed applicant is In-Med Prognostics L3c. It received FDA 510(k) clearance on 2023-09-14 under 510(k) number K220034. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the NEUROShield?

NEUROShield is a medical device that received FDA 510(k) clearance on 2023-09-14. The listed applicant is In-Med Prognostics L3c. The 510(k) number is K220034.

When did NEUROShield receive FDA 510(k) clearance?

NEUROShield received FDA 510(k) clearance on 2023-09-14, under 510(k) number K220034.

Who is the listed applicant for NEUROShield?

The FDA 510(k) record lists In-Med Prognostics L3c as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for NEUROShield?

The FDA product code for NEUROShield is LLZ.

Related Devices (Code: LLZ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K262449AdvaViewADVAHEALTH SOLUTIONS, LLC K261916NeuroQuant PETCortechs Labs, Inc.K260936RadioViewAINeurocareai, Inc. (Dba Savelife.Ai)K260588Cleerly LABSCleerly, Inc.K262462TheraSphere 360™ Y-90 Management PlatformBoston Scientific Corporation K262143ImageGrid StreamVueCandelis, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.